ResMed Inc.
$252.18
+2.01 · +0.80% today
Market open · updated 12:44:26 PM ET
- High
- $252.09 10:55 AM
- Low
- $248.54 6:45 AM
Against the S&P 500 Price change through Oct 27, 2026
RMD+4.12%
S&P 500+12.87%
RMD−3.24%
S&P 500+12.32%
RMD+86.26%
S&P 500+87.41%
RMD−6.46%
S&P 500+69.55%
Key numbers
- Previous close
- $250.17
- Open
- $253.57
- Day's range
- $249.61 – $254.27
- 52-week range
- $180.27 – $277.67
- Volume
- 398,112
- Average volume
- 1.4 million
- Market value
- $35.5 billion
- Price to earnings
- 24.3last 12 months
- Earnings per share
- $10.53last 12 months
- Beta
- 0.75moves less than the market
- Dividend
- $2.46 a year · 0.97%
- 50-day average
- $231.32
- 200-day average
- $225.04
Thursday, Oct 29, 2026, after the close.
Analyst price targets and the full financials are in the terminal.
Who ResMed competes with From our value chain
ResMed in the news
No desk stories on RMD yet. When we write about it, the story leads this list.
- HeadlineUnlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key MetricsZacks Investment Research · October 28, 2026 at 10:16 AM ET
- HeadlineWill ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · October 23, 2026 at 1:11 PM ET
- HeadlineResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?Zacks Investment Research · October 23, 2026 at 9:56 AM ET
- HeadlineResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research · October 22, 2026 at 11:06 AM ET
- HeadlineResmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.GlobeNewsWire · October 19, 2026 at 8:00 AM ET
- CongressRo Khanna bought $1,001 - $15,000 of RMDHouse filing · disclosed Oct 9, 2026
- CongressAlan Armstrong bought $1,001 - $15,000 of RMDSenate filing · disclosed Jul 22, 2026
- CongressRo Khanna bought $1,001 - $15,000 of RMDHouse filing · disclosed Jun 11, 2026
Earnings
Next report: Thursday, Oct 29, 2026, after the close.
Congress trades in RMD
5 purchases and 2 sales in the latest 7 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Alan ArmstrongSenate · R-Oklahoma | Purchase | $1,001 - $15,000 | Mar 27, 2026 | Jul 22, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | May 1, 2026 | Jun 11, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Apr 13, 2026 | May 13, 2026 |
| Kelly Louise MorrisonHouse | Sale | $1,001 - $15,000 | Jun 4, 2025 | Jun 19, 2025 |
| Kelly Louise MorrisonHouse | Sale | $1,001 - $15,000 | Apr 28, 2025 | May 14, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Nov 15, 2024 | Dec 6, 2024 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About ResMed
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 11,370
- Headquarters
- San Diego, California
- Website
- resmed.com
- Listed
- Jun 2, 1995
More medical - instruments & supplies stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.